TMCnet News

BUYINS.NET: AGN, PFG, VRX, HOLX, OSK, RBC Expected To Be Higher After Earnings Releases on Monday
[July 30, 2010]

BUYINS.NET: AGN, PFG, VRX, HOLX, OSK, RBC Expected To Be Higher After Earnings Releases on Monday


Jul 30, 2010 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Monday, August 2nd and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and August earnings reports. Allergan Specialty Therapeutics (NYSE: AGN), Principal Financial Group (NYSE: PFG), Valeant Pharmaceuticals (NYSE: VRX), Hologic (NASDAQ: HOLX), Oshkosh Corp (NYSE: OSK) and Regal-Beloit (NYSE: RBC) are all expected to be higher after their earnings are released Monday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go higher after earnings are released Monday: Symbol Company # of Reports Quarter Release Time AGN Allergan Specialty Ther 12 quarters Q2 Before PFG Principal Financial August earnings Q2 After VRX Valeant Pharmaceuticals August earnings Q2 Before HOLX Hologic Inc August earnings Q3 After OSK Oshkosh Corporation August earnings Q3 Before RBC Regal-Beloit Corp 12 quarters Q2 After Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.



This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Allergan, Inc. (NYSE: AGN), a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, allergy, and retinal diseases; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the Lap-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California.


Principal Financial Group, Inc. (NYSE: PFG) provides retirement savings, investment, and insurance products and services worldwide. It operates in four segments: U.S. Asset Accumulation, Global Asset Management, International Asset Management and Accumulation, and Life and Health Insurance. The U.S. Asset Accumulation segment offers defined contribution pension plans, including 401(k) and 403(b) plans, defined benefit pension plans, nonqualified executive benefit plans, and employee stock ownership plan consulting services to small and medium-sized businesses; investment-only products, such as guaranteed investment contracts and funding agreements to large institutional clients; and the ability to accumulate funds for retirement and savings through mutual funds, individual annuities, and bank products to employees of businesses and other individuals. The Global Asset Management segment provides asset management services covering a range of asset classes, investment styles, and portfolio structures to its other segments and third-party institutional clients. This segment principally offers investment advisory services across three asset classes comprising equity investments, fixed income investments, and real estate investments. The International Asset Management and Accumulation segment offers long-term savings, retirement annuities, asset accumulation, mutual funds, life insurance, mortgage loans, and institutional asset management products and services. The Life and Health Insurance segment provides individual life insurance and group health insurance products and services, as well as other specialty benefits consisting of group dental and vision, group life, group long-term and short-term disability, and individual disability insurance services. The company was founded in 1879 and is based in Des Moines, Iowa.

Valeant Pharmaceuticals International (NYSE: VRX), a specialty pharmaceutical company, engages in the development, manufacture, and marketing of a range of pharmaceutical products. It primarily offers specialty pharmaceutical and over-the-counter (OTC) products in the areas of dermatology and neurology therapeutic classes. The companyas products include Efudex/Efudix for the treatment of multiple actinic or solar keratoses and superficial basal cell carcinoma; Acanya and Atralin gels for the treatment of acne vulgaris; Kinerase, a range of OTC and prescription cosmetic products; Nyal, a range of tablets, liquids, and nasal sprays to treat cough, cold, flu, sinus, and hayfever symptoms; and topical OTC products under the tradenames Dermaveen, Dr. LeWinnas, and Dr. Renaud. It also offers Diastat/Diastat AcuDial, which are gel formulations of diazepam; Cesamet, a synthetic cannabinoid for the management of nausea and vomiting associated with cancer chemotherapy; Mestinon, an orally active cholinesterase inhibitor used in the treatment of myasthenia gravis; Migranal, a nasal spray formulation for the treatment of acute migraine headaches; and Librax, which is used as adjunctive therapy in the treatment of peptic ulcer and irritable bowel syndrome. In addition, the company provides branded generic products in antibiotics, antifungal medications, and diabetic therapies in Europe; and antibacterials, vitamin deficiency, and dermatology in Latin America. Valeant Pharmaceuticals has a license and collaboration agreement with Glaxo Group Limited to develop and commercialize retigabine, a neuronal potassium channel opener for the treatment of adult epilepsy patients with refractory partial onset seizures. It markets its products to physicians, hospitals, pharmacies, and wholesalers through its sales force, as well as through wholesalers primarily in the United States, Mexico, Poland, and Canada. The company was founded in 1960 and is headquartered in Aliso Viejo, California.

Hologic, Inc. (NASDAQ: HOLX) develops, manufactures, and distributes medical imaging systems, and diagnostic and surgical products for serving the healthcare needs of women. The company operates in four segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment offers breast imaging products, such as selenia full field digital mammography system, breast tomosynthesis, screen-film mammography systems, securview workstation, cad systems, stereotactic breast biopsy systems, breast biopsy products, mammosite radiation therapy systems, mammopad breast cushions, and photoconductor coatings. This segment also develops a breast imaging platform, Dimensions, which utilizes a tomosynthesis technology to produce 3D images. The Diagnostics segment provides ThinPrep System, which is primarily used in cytology testing applications, such as cervical cancer screening; Rapid Fetal Fibronectin Test for pre-term birth risk assessment; and Human Papillomavirus Offering and InVitro Diagnostics for cervical cancer tests. The GYN Surgical segment offers NovaSure System, a minimally-invasive procedure that allows physicians to treat women suffering from excessive menstrual bleeding; and Adiana System, a form of permanent female contraception intended as an alternative to tubal ligation. The Skeletal Health segment provides QDR X-Ray Bone Densitometers that assess the bone density of fracture sites; Sahara Clinical Bone Sonometers, which assesses the bone density of heels; Mini C-Arm Imaging Systems that are used to perform minimally invasive surgical procedures on a patientas extremities; and Extremity MRI for detecting rheumatoid arthritis and orthopedics. Hologic, Inc. sells its products through a combination of direct sales and service force, and a network of independent distributors and sales representatives primarily in the United States, Europe, and Asia. The company was founded in 1985 and is headquartered in Bedford, Massachusetts.

Oshkosh Corporation (NYSE: OSK) designs, manufactures, and markets a range of access equipment, specialty vehicles, and vehicle bodies worldwide. Its Defense segment manufactures severe-duty, heavy, and medium-payload tactical trucks for the Department of Defense, including hauling tanks, missile systems, ammunition, fuel, and cargo for combat units. The companyas Access Equipment segment offers aerial work platforms and telehandlers used in a range of construction, agricultural, industrial, institutional, and general maintenance applications. Its Fire and Emergency segment provides custom and commercial fire apparatus and emergency vehicles, including pumpers, aerial and ladder trucks, tankers, light and heavy-duty rescue vehicles, wildland rough terrain response vehicles, mobile command and control centers, bomb squad vehicles, hazardous materials control vehicles, and other emergency response vehicles. The company also manufactures towing and recovery equipment, airport snow removal vehicles, custom ambulances for private and public transporters and fire departments, mobile medical vehicles, and custom vehicles for the broadcast and communications industry. In addition, this segment engages in the installation of equipment, as well as sale of chassis and service parts. Its Commercial segment produces and sells front and rear discharge concrete mixers, and portable and stationary concrete batch plants for the concrete ready-mix industry; and field service vehicles and truck-mounted cranes for the construction, equipment dealer, building supply, utility, tire service, and mining industries. This segment also offers lease financing to concrete mixer customers, concrete batch plant customers, and commercial waste haulers. The company was formerly known as Oshkosh Truck Corporation and changed its name to Oshkosh Corporation in February 2008. Oshkosh Corporation was founded in 1917 and is based in Oshkosh, Wisconsin.

Regal Beloit Corporation (NYSE: RBC), together with its subsidiaries, manufactures and sells electrical and mechanical products to original equipment manufacturers, distributors, and end users. The company operates in two segments, Electrical and Mechanical. The Electrical segment offers heating, ventilation, and air conditioning motors; alternate current (AC) and direct current (DC) commercial and industrial electric motors; and electric generators and controls, and capacitors. These products are used in various industrial applications, such as compressor, pump, paper, and steel processing and power plants. This segment also produces precision servo motors, automatic transfer switches, paralleling switchgears, and a line of AC and DC adjustable speed drives. The Mechanical segment offers a range of mechanical motion control products, including worm gear, bevel gear, helical gear, and concentric shaft gearboxes; marine transmissions; after-market automotive transmissions, and ring and pinions; custom gearings; gear motors; electrical connecting devices; and manual valve actuators, which are primarily used in oil and gas, water distribution and treatment, and chemical processing applications. The company sells its products through its direct sales force and manufacturersa representative organizations in the United States, Canada, Mexico, India, Australia, Thailand, China, and Europe. Regal Beloit Corporation was founded in 1955 and is based in Beloit, Wisconsin.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Thomas Ronk, CEO, SqueezeTrigger.com WWW: http://www.SqueezeTrigger.com Tel: +1 800 715 9999 e-mail: [email protected] ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected].

[ Back To TMCnet.com's Homepage ]